Clinical Trials
106 trialsNCT04980495 2026-05-27
ADAPT NXT
argenx
Phase 3 Completed
NCT05332210 2026-04-28
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 3 Completed
NCT07532707 2026-04-16
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
Damascus University
Phase NA Completed
NCT06471361 2026-03-27
A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT07472777 2026-03-16
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Completed
NCT06718855 2026-02-19
MYCOG
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Completed
NCT04818671 2026-01-22
ADAPTSC+
argenx
Phase 3 Completed
NCT06764160 2026-01-15
ECU-MG-304
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT07319689 2026-01-06
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
Completed
NCT03971422 2025-12-24
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT07291713 2025-12-18
Psychological Health and Adverse Childhood Experiences in Myasthenia Gravis: Online Mental Health BMI Learning Program
Shin Kong Wu Ho-Su Memorial Hospital
Phase NA Completed
NCT05451212 2025-11-10
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
Cabaletta Bio
Phase 1 Completed
NCT05681715 2025-11-06
A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
UCB Pharma
Phase 3 Completed
NCT05230082 2025-09-18
Acupuncture in Myasthenia Gravis (AcuMG)
HealthPartners Institute
Phase NA Completed
NCT04431895 2025-09-16
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Huashan Hospital
Phase EARLY_PHASE1 Completed
NCT07154095 2025-09-04
A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants
West China Second University Hospital
Phase 1 Completed
NCT05514873 2025-09-03
An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
UCB Pharma
Phase 3 Completed
NCT05979688 2025-08-08
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
University of Alabama at Birmingham
Phase NA Completed
NCT04115293 2025-07-16
RAISE
UCB Pharma
Phase 3 Completed
NCT06158815 2025-07-15
Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis
Hacettepe University
Phase NA Completed
NCT07022028 2025-06-18
GUIMAUVE
Poitiers University Hospital
Completed
NCT03818204 2025-06-13
Clinical Trial to Improve the Magnetic Levator Prosthesis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT05737160 2025-05-23
Study of Telitacicept in Generalized Myasthenia Gravis
RemeGen Co., Ltd.
Phase 3 Completed
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT04678115 2025-04-22
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Massachusetts Eye and Ear Infirmary
Phase NA Completed
NCT04650854 2025-04-18
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT06436768 2025-04-02
Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
Beijing Tongren Hospital
Phase NA Completed
NCT05992025 2025-03-30
DIG-MG
Uppsala University
Phase NA Completed
NCT06381284 2025-03-25
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
ZS Associates
Completed
NCT05566964 2025-03-10
Descriptive Analysis of Real-world Data Collected with ME&MGopen
Ad scientiam
Completed
NCT06860347 2025-03-06
Biomarkers for Fatigue in Patients with Myasthenia Gravis
Leiden University Medical Center
Completed
NCT06860360 2025-03-06
Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis
Leiden University Medical Center
Completed
NCT06501794 2024-12-18
Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients
University of Liverpool
Phase NA Completed
NCT03759366 2024-12-11
A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT02950155 2024-10-26
Rinomax
Karolinska Institutet
Phase 3 Completed
NCT06624345 2024-10-16
Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization
Chang Gung University
Phase NA Completed
NCT05890833 2024-09-19
The Risk of Falls Index for Patients With Neuromuscular Disorders
LMU Klinikum
Completed
NCT02965573 2024-08-28
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
argenx
Phase 2 Completed
NCT04176211 2024-06-03
The Impact of Myasthenia Gravis in the Real World
Vitaccess Ltd
Completed
NCT03920293 2024-05-28
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT02118805 2024-04-16
QUESST
Beth Israel Deaconess Medical Center
Completed
NCT03304054 2024-03-12
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Catalyst Pharmaceuticals, Inc.
Phase 3 Completed
NCT06256172 2024-02-13
Medlink
Olawuyi Racett Nigeria Ltd
Phase NA Completed
NCT03863080 2023-12-20
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
Immunovant Sciences GmbH
Phase 2 Completed
NCT05945784 2023-12-06
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
Casa Colina Hospital and Centers for Healthcare
Completed
NCT06101407 2023-10-26
Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients
Vietnam Military Medical University
Completed
NCT04695379 2023-10-06
CO-MY-COVID
University Hospital, Bordeaux
Completed
NCT04124965 2023-09-05
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Completed
NCT03770403 2023-07-14
ADAPT+
argenx
Phase 3 Completed
NCT03772587 2023-06-27
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
Momenta Pharmaceuticals, Inc.
Phase 2 Completed